This year’s Iraty Award for Research in Retinal Diseases honors Leo A. Kim, MD, PhD, an Associate Professor of Ophthalmology at Harvard Medical School (HMS) and the Monte J. Wallace Ophthalmology Chair in Retina at Mass Eye and Ear. The award, which...
Leo A. Kim, MD, PhD, a clinician scientist with surgical expertise and an innovator in the treatment of retinal diseases associated with neovascularization and fibrosis and an Associate Professor of Ophthalmology at Harvard Medical School, will serve as...
Regulating transcription factor RUNX1 using small molecule drugs a promising novel therapy for diseases of the retina, including advanced diabetic eye disease. Boston, Mass.— A team led by Massachusetts Eye and Ear researchers has identified a novel...
Leo Kim, MD, PhD, received a grant from the E. Matilda Ziegler Foundation for the Blind, Inc. in the amount of $80,000 over three years for his project studying Runx1 in retinal neovascularization. He is working on this project in collaboration with...
Faculty Recognition Joseph Arboleda-Velasquez, MD, PhD, received a grant from the National Institute of Neurological Disorders and Stroke and National Institute of Aging/National Institutes of Health in the amount of $1,016,301 over five years for his...
New findings may stimulate the development of targeted therapies for proptosis in patients with acute thyroid eye disease Boston, Mass. — Researchers from Mass. Eye and Ear - including Schepens Eye Research Institute - and Boston Children's Hospital have...
Faculty Awards Joseph Arboleda-Velasquez, MD, PhD, and co-PI, Leo Kim, MD, PhD, received a Department of Defense grant in the amount of $1,499,592 over three years, for their project, "Testing the Preclinical Efficacy of Therapies for Proliferative...
On October 7 th and 8 th, Jason Comander, MD, PhD, and Leo Kim, MD, PhD, participated in the Alliance for Eye and Vision Research (AEVR) Emerging Vision Scientists Program. This program allows scientists to meet with members of Congress to discuss the...